Pharmaceuticals

Liraglutide Sector Forecast Shows Robust Momentum, Climbing to $10.23 Billion With 8.3% CAGR

February 16, 2026February 16, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the liraglutide market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Liraglutide Market expected to grow between 2026 and 2030?

The liraglutide market size has seen substantial growth over recent years. It is anticipated to increase from $6.88 billion in 2025 to $7.45 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.2%. This historical expansion can be attributed to factors such as the rising global prevalence of type 2 diabetes, the clinical success observed with glp-1 receptor agonists, the demand for therapies that address both glucose control and weight management, the approval of liraglutide for both diabetes and obesity indications, and the growing confidence among physicians in injectable incretin therapies.

The liraglutide market is projected to experience substantial expansion over the coming years, reaching $10.23 billion by 2030, driven by a compound annual growth rate (CAGR) of 8.3%. This anticipated growth during the forecast period is primarily fueled by factors such as the increasing global prevalence of obesity, a growing inclination towards diabetes treatments that prioritize weight management, the expansion of screening initiatives for metabolic disorders, a heightened patient demand for effective appetite-suppressing treatments, and ongoing advancements and public awareness surrounding GLP-1 based therapies. Key trends anticipated during this period encompass the widespread uptake of liraglutide in managing type 2 diabetes, its increasing application in medical weight management, the expanding acceptance of injectable GLP-1 therapies, the development of comprehensive long-term metabolic disease management programs, and an amplified emphasis on the dual advantages of achieving both glycemic control and weight reduction.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18659&type=smp

Which Drivers Are Influencing Market Acceleration In The Liraglutide Market?

The growing diabetic population is anticipated to drive the expansion of the liraglutide market in the future. Diabetes is a chronic condition where the body struggles to properly manage blood sugar levels, either from insufficient insulin production or ineffective utilization of insulin. The prevalence of diabetes is increasing globally due to factors such as sedentary lifestyles, unhealthy diets, and rising obesity rates. Diabetes medications like liraglutide work by mimicking the action of the GLP-1 hormone, which boosts insulin secretion, lowers blood sugar, and aids in weight loss, thereby assisting in the management of type 2 diabetes. For example, in March 2024, a report from the Government of the United Kingdom, a UK-based information website, indicated that in March 2023, the proportion of individuals with type 1 diabetes in England receiving all 8 care processes at GP practices involved in the NDA rose to 43.8%, compared to 35.2% the year before. Consequently, the rising diabetic population is propelling the growth of the liraglutide market.

What Segments Are Identified Within The Structure Of The Liraglutide Market?

The liraglutide market covered in this report is segmented –

1) By Brands: Victoza, Saxenda

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Drug Stores, Online Pharmacies

3) By Type Of Application: Diabetes Treatment, Weight Management

4) By End-Users: Hospitals And Clinics, Homecare Settings

Subsegments:

1) By Victoza: Type 2 Diabetes Treatment Or Weight Management

2) By Saxenda: Weight Loss Treatment Or Obesity Management

Which Trends Are Shaping Activity Within The Liraglutide Market?

Leading firms within the liraglutide market are innovating with new products, like generic GLP-1, aiming to broaden therapeutic choices and meet the market’s need for more budget-friendly options. Generic GLP-1 denotes variants of GLP-1 receptor agonists manufactured once the patent on their original branded counterparts has lapsed, providing economical solutions for managing conditions such as type 2 diabetes and obesity. An example of this is the June 2024 launch by Teva Pharmaceutical Industries Ltd., an Israel-based pharmaceutical company, of the first generic GLP-1, akin to Victoza, into the U.S. market, thereby satisfying the growing need for these treatments. Liraglutide injections are prescribed to improve blood glucose control in adults and children aged 10 and above living with type 2 diabetes, as well as to decrease the likelihood of cardiovascular events in adults who have type 2 diabetes along with pre-existing cardiovascular conditions.

Which Major Industry Participants Are Leading The Liraglutide Market Growth?

Major companies operating in the liraglutide market are Novo Nordisk A/S

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/liraglutide-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Liraglutide Market?

North America was the largest region in the liraglutide market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the liraglutide market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Liraglutide Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18659&type=smp

Browse Through More Reports Similar to the Global Liraglutide Market 2026, By The Business Research Company

Liraglutide Market Report 2026

https://www.thebusinessresearchcompany.com/report/liraglutide-global-market-report

Liraglutide And Semaglutide Market Report 2026

https://www.thebusinessresearchcompany.com/report/liraglutide-and-semaglutide-global-market-report

Lisinopril Market Report 2026

https://www.thebusinessresearchcompany.com/report/lisinopril-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795